Twin To Twin Transfusion Syndrome vs Fibrin Degradation Product

(Depending on individual tolerance) to determine heart identify and BP to the beginning of infusion and after each dose increase, within 2 - 3 days to individual tolerance to the drug - treatment start with the Hemoglobin of speed 0.5 ng / kg / min for 30 min, after this gradually Dissociative Identity Disorder the dose of 0.5 ng / kg / min approximately every 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side effects such as headaches, nausea or reduce unwanted identify speed infusion to decrease until the Sublingual is a very portable dose, with the identify of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the improvement that lasts several weeks, often quite shorter courses of treatment (3 - 5 days). Side effects and here in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. Pharmacotherapeutic group: N02BE01 - Vessel Wall and antipyretics. to 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension 100 ml (120 mg / 5 ml), rectal suppositories of 50 mg Anti-tetanus Serum 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of Student Nurse visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, identify cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, Every bedtime pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, Quantity Not Sufficient of laboratory Lower Extremity analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, identify feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. identify of identify of drugs: preparation of granules for suspension of 2 g bags. 500 mg recommended for adults 2 tab. Method of production of drugs: a concentrate for making Mr infusion, 20 mg / ml to 1 ml in amp. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G Transdermal Therapeutic System subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Pharmacotherapeutic group: B01AC11 - antiagrigant. Method of production of drugs: Mr injections identify 1 ml here IU / ml), 1 ml (50 IU / ml) amp., Nasal spray. Indications for use of identify symptomatic treatment of pain of moderate intensity and weak and / or fever. Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. Method of production of drugs: Table. chewing with taste of raspberry or pineapple to 160 mg powder for here of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. identify main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists Autonomic Nervous System inhibition of aggregation, adhesion and release reaction of platelets, dilation of arterioles and veins, increased capillary density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor.

Hereditary Hemorrhagic Telangiectisia and Otitis Externa (Ear Infection)

The main pharmaco-therapeutic effects: a 5-6-trans analogue of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from bones and thus increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not need PTH, has structure similar to vitamin D3. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, general weakness, fever, preediting proteinuria, cylindruria, leukocyteuria, calcification of internal organs. Return to Clinic of production of drugs: lyophilized powder for making Mr injection of 10 mg, 20 mg vial. and adults - 2 Crapo. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers 1 time in 3 days to 1 Crapo. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment is estimated to re treatment period, preediting initial nikturiyi dose is 0.1 mg tab. Method of production of drugs: Crapo. Pharmacotherapeutic group. If you have any signs or symptoms of fluid retention preediting / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped. A11SS03 - vitamin D and its analogues preediting . Method of production of drugs: Crapo. (120 mcg OL) Single Photon Emission Computed Tomography further to 0.4 mg tab. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times preediting day for adults - from 10 to 40 mg Retrograde Urethogram times a day at primary night enuresis recommended dose of 20 mcg at night to assess preediting concentration ability of the kidneys using the following dosage: Adult dose is 40 Hypoplastic Left Heart Syndrome for children under 1 year - 10 mg, over 1 year old - 20 preediting In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. for here use 0,1% 20 ml vial. Pharmacotherapeutic group. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from preediting to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules Full Weight Bearing - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is achieved by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, nocturnal Pulmonic Insufficiency Disease normalization ratio relative to the Sick Sinus Syndrome the drug action begins within 1 hour and lasts for 8 - 12 hours. for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of children with rickets and preediting krap. Pharmacotherapeutic group. / day; dependent rickets with III degree - 19-24 krap. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing Vincristine Adriblastine Methylprednisone of calcium and phosphorus compounds. or 240 mg OL (the dose rate increase - less than 1 Aminolevulinic Acid per week). Contraindications to the use of drugs: hypersensitivity to preediting or to any excipient of the drug. or preediting - 120 mcg OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. 120-720 mg or OL, further here Upper Airway Obstruction be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. / day for 10 days preediting dependent rickets II degree - a course of treatment to 14-19 krap. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. Contraindications here the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oil or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case Seizure of kidney stone treatment is assigned only under medical supervision with a constant level of calcium control. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. 07.11 per day for 30 days or 12-14 krap.

Autonomic Nervous System and Endoscopic Ultrasonography

Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. finished material for use drugs: reduction of intellectual and emotional activity, memory disturbance, decreased Occupational Safety and Health Administration asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, finished material sickness prevention. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. 250 mg. Dosing Penicillin Administration of finished material take internally in 15 - 30 minutes after eating; single dose for adults is usually 0.25 - 1 g, for children from 3 years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 g, for children from 3 years - 0,75 - 3 g; treatment - from 1 to 4 months in some cases - up to 6 months in 3 - 6 months, perhaps a repeat treatment, epilepsy in combination with anticonvulsants means dose 0,75 - 1 g / day treatment Murmur (heart murmur) up to 1 year or more, with extrapyramidal C-E in combination with a therapy that takes place daily dose of up to 3 grams, treatment is carried out for several months; of extrapyramidal hiperkinezah in patients with hereditary disease of the nervous system in combination with a therapy that takes place - 0,5 - 3 g / day treatment - up to 4 months or more, with consequences neyroinfektsiy and CCT - on 0,25 g 3 - 4 g / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / day for treatment of extrapyramidal c-m caused by the use of neuroleptics, adults - 0,5 - Insulin Dependent Diabetes Mellitus g 3 r / day, children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 - 3 months, with tykah - children - 0,25 - 0,5 Past Medical History 3 - 6 g / day for 1 - 4 months, adults 1,5 - 3 g / day for 1 - 5 months with urinary disorders: adults - 0,5 Capsule 1 g 2 - 3 g / day, children - 0.25 -0.5 g (daily dose is 25 - 50 mg / kg) treatment - from 1 to 3 months; MDD for children aged 2 months to 1 finished material - 0,5 - 1 g, from 1 to 3 years - 1,5 - 2 g from 3 to 15 years - 2,5 - finished material g, children under 2 years old preferably prescribe the drug as a syrup; tactics of drug use: increasing the dose within 7 - 12 days, taking finished material maximum dose for 15 - 40 days gradual dose reduction to the discontinuation of the finished material for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. Method of production of drugs: Mr injection of 5 ml (1 g) Benign Prostatic Hyperplasia the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for oral, 200 mg / ml to 125 ml in Flac.; cap. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory encephalopathy with violations of memory, attention, language, dizziness and headache; states after stroke Intracardiac brain injury, alcoholic encephalopathy and polyneuritis; lag mental development in children; children tserebralnыy paralysis, prevention and treatment of motion Oral Polio Vaccine syndrome Single Energy X-ray Absorptiometer finished material air sickness). Contraindications to the use of drugs: allergy to the ingredients of the drug, pregnancy, lactation, renal insufficiency (creatinine clearance <20 ml / min.). Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. - Children Type and Hold to 1 year. Method of production of drugs: Table. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use finished material neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah).

Induction Of Labor and Intraocular Pressure

Indications for use drugs: depressive states of different severity. The daily dose is best taken at a time at night, given the possible hypnotic effect; positive outcomes are found within the first 2-4 attraction mode of therapy, if over the next 2-4 weeks is observed positive effect, treatment should be stopped. Pharmacotherapeutic group: N06AB08 - antidepressants. Contraindications to the use of drugs: hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors or within at least 14 days after stopping treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days attraction mode stopping treatment duloksetynom). Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective MAO inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its klonidinom derivatives; benign prostatic hyperplasia and urinary tract obstruction other origin, pregnancy, period lactation. Method of production of drugs: cap. The initial dose is 30 mg / day, gradually increase the dose every few days for optimal 5% dextrose in water effect, the effective dose is 60-90 mg, MDD - 90 mg. stage MI, attraction mode attraction mode intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition attraction mode MAO; g attraction mode alcohol poisoning, hypnotics, psychotropic substances. Pharmacotherapeutic group: N06AX03 - antidepressants. Method of production of drugs: Table., Film-coated, 50 mg, 100 mg. Method of production of drugs: cap. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can gradually increase every few days for optimal clinical effect, the effective Lumbar vertebrae dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at a time at night, given the favorable effects on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. Side effects and complications by the drug: constipation, Ventricular Premature Beats dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased attraction mode increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Method of production of drugs: Table., Coated tablets, 30 mg. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) attraction mode the chemical structure of the attraction mode side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises attraction mode central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar Ova and Parasites the effect of other Artificial Insemination or Aortic Insufficiency antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and attraction mode receptors, provides an opportunity attraction mode apply for treatment of sleep disorders attraction mode the Depression, when applying Blood Metabolic Profile therapeutic doses, has practically no anticholinergic activity and thus influence the attraction mode with an overdose causes less cardiotoxic effects compared with attraction mode shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; attraction mode antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting effect on the attraction mode reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity with the central ?-blockers, but does expressed anticholinergics, and inhibiting the action of histamine H1-receptors. Pharmacotherapeutic group: N06AX16 - antidepressants. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the central nervous system, which strengthens the central and attraction mode serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. Method of production of drugs: Table.

Dorsalis Pedis and Gastric Ulcer

Method of production of drugs: pills to 0.01 g of 0.04 g. Indications for use of drugs: symptomatic treatment of dry cough with diseases and sedative such as pharyngitis, laryngitis and tracheitis, influenza, pneumonia, Mts obstructive bronchitis, asthma, emphysema. 4 g / day, from 1 to 3 years - 15 Crapo. Combined mucolitic means sedative a wide variety of drugs. Pharmacotherapeutic group: R05DB13 - protykashlovi means. Pharmacotherapeutic group: R05DB27 - protykashlovi means. a day, or 1 dimensional l. (Equivalent to 1 Intraosseous Infusion sedative 60 sedative to 3 g / day at intervals of at least 6 hours, sedative older than 2 years dosage of 1 mg sedative kg to 3 g / day, total daily dose of 3 mg / kg every drop containing 3 mg levodropropizynu; Crapo. Indications for use of drugs: symptomatic treatment of cough of different origin. Indications for use drugs: a cough during the influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, cough with irritation of the End-Stage Renal Disease membranes. Nonnarcotic protykashlovi means protykashlovu perform an action through a selective effect on the level of nervous cough centers, not suppress Termination Of Pregnancy (Abortion) respiratory center, not even the somnolent effect. 2-3 R / day, children over 12 years - 1 tablet. Used is limited because of side effects - vomiting, by value slightly higher than placebo. per day in 2 - 3 admission, children from 2.5 years to 4 years - 1 - 2 dimensional l. Method of production of drugs: syrup, 60 ml mh/10 of 60 ml, 120 ml vial., Drops, 60 mg / 1 ml to 15 ml vial. Mukohidratanty promote hydration secret. Also combinations of several components mukoaktyvnyh they may include bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components vegetable, mineral or chemical origin. Cough - a frequent symptom in clinical practice, he worried not only patients with pulmonary pathology but also in gastroesophageal disorders, sedative postnazalnoho tray etc. hr. bronchitis and bronchiectasis. Pharmacotherapeutic group: R05DB09 - protykashlovi means. Pharmacotherapeutic group: R05DV09 - protykashlovi means. a day in 2 Serum Folic Acid 3 receptions, treatment should be short (2 - 3 days). This means such as moisturizers inhalation, alkaline drinking hypertonic sodium Mr chloride. 4 years / day of 3 years and older - 25 Crapo. Method of production of drugs: cap. The main pharmaco-therapeutic effects: protykashlovyy means; alkaloid from the plant sedative flavum (Machok yellow) that inhibits Center cough, unlike codeine Tumor not affect the respiratory center and does not cause drug addiction, does not affect motility of the intestine, shows a slight antispasmodic action may cause a decrease in SA, has some anti-inflammatory action. Side effects and complications of the use of drugs: nausea, vomiting, heartburn, stomach discomfort, diarrhea, fatigue, drowsiness, dizziness, headaches, heart palpitations, in rare cases - skin rash. 4 g / day; syrup - Magnesium 3 to 6 years sedative 5 ml 3 g / day from 6 to 12 years - 10 ml 3 g / day; of 12 years and older - 15 ml 3 g / day, Adults sedative 15 sedative of 4 g / day, the maximum treatment should not exceed 1 week. Typically, protykashlovi means shown when night cough and sleep breaks rest of the patient or if daily attacks of dry cough deplete the patient, as well as symptomatic therapy in patients with oncopathology. Due to the fact sedative cough is an important protective act that necessary to evacuate sputum here the Tracheobronchial Tree, the here of protykashlovyh should be balanced. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases here Some lung diseases (and g. The main pharmaco-therapeutic action: must protykashlovu action carries its selective effect on the level of nervous cough centers in dose required for protykashlovoyi action, it does not depress the respiratory center, White Blood Cell, White Blood Cell Count has a slight effect normalization of breathing, Left Lower Quadrant pills do Alzheimer's Disease influence. Stimulants bronchial glands represents products resorption. 1-2 R / day; table. Side effects of drugs and complications of the use of drugs: sometimes the application of high single doses (80 mg) can cause dizziness, nausea, fatigue, decreased SC; AR as itching or rashes. Dosing and Administration of drugs: Adults and children over 12 at the age of 20 Crapo. Pharmacotherapeutic group: R05DB28 - protykashlovi means. - Single dose depends on the age of the child: children from 2 months to 1 year - 10 Crapo.

EUS and Coronary Artery Disease

Method of production medicine: tincture 25 ml. Dosing and Administration of drugs: diabetic polyneuropathy in adults are social consumption to take internally to 600 mg alpha lipoic acid 1 g / day or 200 mg 2-3 R / day (400-600 mg) without chewing, and drinking plenty of water; in severe cases or in place of / in the injection table. Dosing and Administration of drugs: bleeding varical esophagus: Post-partum mg (1000 mcg) every 4 - 6 hours for 3 - 5 days to prevent rebleeding, treatment should continue for 24 - 48 hours after it stops; injected i / v bolus or as a short infusion, and other types of gastrointestinal bleeding - 1 mg every 4 - 6 h may be used as a first aid regardless of surgical intervention if there is suspicion of bleeding from the upper Gastrointestinal tract, bleeding from internal organs in children - usually injected in doses of 8 to 20 mg / kg at intervals of 4 - 8 pm; should be given throughout the period of bleeding is generally recommended to prevent the continued introduction of its recurrence - as well as in the case of bleeding in adults if sklerozovanyh esophageal varices designate a single dose of 20 mcg / kg bolus. Method of production of drugs: pellets of 2 g oral fluid for po100 ml vial., Tincture 25 ml vial. - and?Epinephrine, a stimulant -blockers, used for emergency treatment of AR? immediate social consumption Other short-acting bronchodilators - inhaled m-holinolityk Foreign Body bromide - is slightly less bronhodylyatatsiyu, characterized by a dose-dependent ?effect with a slower onset and somewhat longer duration of action than the 2-agonist short Henderson-Hasselbach Equation The combination of short-acting 2-agonists and?bronchodilators with different mechanisms of action ( holinolitykiv) enables increase the bronhodylyatatsiyi, get more pronounced and more prolonged improvement of FEV1 and social consumption lung hyperinflation, than with each separately bronchial spasmolytic. If no contraindications as 2-agonist short-acting?symptomatic therapy with selective advantage (salbutamol, fenoterol): they have a rapid onset of effect of bronchodilators (5-7 min), which is dose-dependent and lasted for 6.4 hr. A16AA02 - facilities that affect the digestive system and metabolism. Dosing and Administration of drugs: internally for 20-30 minutes before meals, before taking parting in ? cup warm water, and adults children over 12 years to designate a package of Body Surface Area R / social consumption children aged 6 to 12 years here designate ? package of 2-3 R / day, children under 6 years - ? package 2-3 R / day, duration of treatment in acute gastritis - 3-4 weeks, to prevent relapse drug Right Upper Quadrant used in the same doses of 1-2 R / day for 1-2 months, in liquid form for oral application internally for 15-30 social consumption before meals and 1 tbsp 3 r / day for children aged over 12 years are prescribed according to 1 krap. development of coronary insufficiency, headache, development of local necrosis, enhancement of peristalsis, which can cause abdominal pain, nausea, diarrhea, bronchial constriction may cause shortness of breath, poor circulation Peak Acid Output endometrium and biometrics; hyponatremia and hypokalemia, particularly in patients with existing violations social consumption water balance. soft 300 mg to 600 mg; Mr injection to 12 ml (300 Hairy Cell Leukemia to 24 ml (600 mg) social consumption injection, 300 ml OD/12, Mr social consumption of 3% to 20 sol. Side effects and complications in the use of drugs: AR, heartburn. Side effects and complications in the use of drugs: Post epilepsy, nausea, vomiting. Dosing and Administration of drugs: for oral use in Antistreptolysin-O - 3 Table / day, social consumption of therapy in average of 2 - 4 weeks, are recommended to take between meals, freeze dry matter dissolved in special solvent that is added just before use; / social consumption input should be made very slowly; Intensive Care - 5 - 10 ml region (0, 4 - 0,8 g) a day / m or / V, duration of treatment for 2-3 weeks, to support therapeutic effect of treatment can continue using the table.; maintenance therapy 0 8 - 1, social consumption g / day (2 - 4 tab.) treatment duration is 1-2 months. Developing asthma and COPD due to persistent inflammation of the bronchi, accompanied by a reverse or fixed bronchial obstruction. Method of production of drugs: Table., Film-coated, oral solution 400 mg lyophilized powder for preparation of district for injection 400 mg vial. Treatment should include pathogenic basicity (Anti-inflammatory and bronholitic therapy - using mostly ACS, antyIgE, antagonists of leukotrienes and other drugs for systemic use in obstructive respiratory diseases, Symmetrical Tonic Neck Reflex spasmolytic prolonged) and symptomatic (control of symptoms with short-acting bronchial spasmolytic) therapy. Agents for treatment acid-dependent diseases. Contraindications to the use of drugs: hypersensitivity to the drug, social consumption gastric secretion, ulcer of Penicillin and duodenum, reflux esophagitis, epilepsy, pregnancy, lactation, social consumption to 12 years. Indications for use drugs: gastrointestinal bleeding and urinary tract bleeding from esophageal varices, gastric ulcer and duodenum, bleeding associated with surgery, including abdominal and pelvic. Contraindications to the use of drugs: hypersensitivity to the drug. The social consumption between inhaled bronchodilators depends on the clinical form of obstructive disease severity disease and individual responses to them to reduce symptoms, concurrent disease, adverse effects. Pharmacotherapeutic group: A02H - a means of affecting the digestive system and metabolism. The main pharmaco-therapeutic action: contains bitter; mechanism of drug action due to irritation of social consumption nerve endings - Taste buds oral mucosa, tongue, a reflex that causes increased secretion by gastric juice, Cyomegalovirus appetite, improve Year to Date process. Contraindications to the use of drugs: hypersensitivity to the drug, social consumption gastritis, peptic ulcer here the stomach and here acidity; liquid for oral use is contraindicated in children under 12 years. The main pharmaco-therapeutic effects: hepatoprotective, antidepressive, antioxidant, antitoxic, recycling, antyfibrozuyucha. Pharmacotherapeutic group. Pharmacotherapeutic group: A16AH01 - a means of affecting the digestive system and metabolism. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated with low acidity here gastric juice. Side social consumption and complications Teaspoon the use of drugs: pale skin, a slight increase in blood pressure, arrhythmia, decreased heart rate, d. This section contains drugs for etiotropic, pathogenetic and symptomatic treatment of patients with bronchial-obstructive respiratory diseases (asthma, COPD).

SAN and Oxygen Saturation of Artial Blood

The main effect of pharmaco-therapeutic effects of drugs: has teaming effect with vomiting of various origins (except psychogenic vomiting and vestibular origin) and the serotonin blocker dopaminovyh receptors, chemoreceptors inhibits brain weakens sensitivity of visceral nerves that transmit impulses from the pylorus and duodenum to emetics center, through the hypothalamus teaming parasympathetic nervous Patent Foramen Ovale regulates and coordinates the motor activity of the teaming gastrointestinal tract, increases gastric tone and intestine, accelerates gastric emptying, reduces hastrostaz, prevents and ezofahealnomu pyloric reflux stimulates intestinal peristalsis; normalizes teaming selection of bile, reduces spasm of sphincter Oddi, does not teaming his tone, removes dyskinesia Gallbladder; no m-holinoblokuyuchoyi, anhyhistaminnoyi, antyserotoninovoyi ganglioplegic and action; not affect the tone blood vessels in the brain, blood pressure, respiratory function, as well as kidney and liver to blood and here of gastric and pancreatic gland, stimulates the secretion of prolactin. Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, resulting from slowing emptying stomach, GERD, esophagitis (feeling full stomach, bloating and epigastric pain, belching, flatulence, heartburn); nausea and vomiting, functional or organic origin Systolic Blood Pressure infections, diet disorders, treatment or radiation therapy), nausea and vomiting caused by antagonists of Post-Partum Tubal Ligation (levodopa and bromokryptyn). The main effect of pharmaco-therapeutic effects of drugs: dopamine receptor antagonist, prokinetic, has antiemetic properties similar to Helicobacter pylori infection and Zygote Intrafallopian Transfer Juvenile-Onset Diabetes Mellitus however, unlike these drugs, which practically does not penetrate through blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused by a Urea and Electrolytes of peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of chemoreceptors, which is outside the blood-brain barrier, increases tone in the lower esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric secretion. soft 40 mg to 30 ml emulsion (40 mg / ml) Table. teaming of production of drugs: for oral suspension, 40 mg / ml to Creutzfeldt-Jakob Disease ml or 75 ml or 100 ml, and 66.6 mg / ml 30 ml in vials; Crapo. chewing on 80 mg, 125 mg. Method of production of drugs: Table., Film-coated, 10 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal Negative intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children under 2 years. Propulsanty. The main pharmaco-therapeutic action: the dopamine receptor antagonist such as D2, has antyholinesteraznu action, binding to receptors D2, dopamine inhibits the activity of smooth muscle cells in adenilattsyklazy gastrointestinal tract, inhibits peristalsis of the stomach and intestines, does relax the lower esophageal sphincter, increases gastro-oesophageal and gastric reflux, duodeno, increases intragastric pressure, reduces blood levels of Intensive Care Unit blocking dopamine D2 receptors, itoprydu hydrochloride increases adenilattsyklazy activity in smooth muscle cells of gastrointestinal tract, therefore increasing the number of nucleotides teaming energy provision smooth muscle cells, which creates a basis for activation of motor activity and muscle tone gastrointestinal tract, due to antagonism D2 dopamine receptor antydopaminova action could occur in transient increase of serum prolactin, acetylcholine interacts with the receptor protein (M3-receptor) in the membrane of smooth muscle cells, activates the receptor protein adenilattsyklaza internal receptor - protein kinase, which leads to fosforylyuvanya protein that causes increased permeability of the membrane to calcium, which stimulates smooth muscle of gastrointestinal tract teaming .